Association between single nucleotide polymorphism rs11057401 of CCDC92 gene and the risk of coronary heart disease (CHD)

• Published in: Lipids in health and disease Vol. 17; no. 1; pp. 28 - 5
• Main Authors: Xiao, Lingyan, Shi, Dongyang, Zhang, Hui, Zhang, Yanchun, Liu, Yongfu, Lu, Hu, Zheng, Yishan
• Format: Journal Article
• Language: English
• Published: London BioMed Central 13.02.2018; BioMed Central Ltd; BMC
• Subjects: Analysis; Biomedical and Life Sciences; CCDC92 gene; Clinical Nutrition; Coronary artery disease; Coronary heart disease; Genetic aspects; Han (Chinese people); Health aspects; Health risk assessment; Ischemic stroke; Life Sciences; Lipidology; Lipids; Medical Biochemistry; Risk factors; Single nucleotide polymorphism; Single nucleotide polymorphisms; Lipids; Single nucleotide polymorphism; Ischemic stroke; CCDC92 gene; Coronary artery disease
• ISSN: 1476-511X; 1476-511X
• DOI: 10.1186/s12944-018-0672-1

Background Given that the CCDC92 (coiled-coil domain containing 92) was important in insulin resistance, we sought to investigate whether the CCDC92 rs825476 SNP is associated with the risk of CHD in Chinese Han population. Methods Rs11057401 was genotyped for 817 patients with CHD and 724 age- and sex-matched controls using PCR-based Invader assay with the probe sets designed and synthesized by third wave. Results Patients were found to have a significantly higher frequency of AA than the controls (23.5% vs. 14.7%, OR = 1.60, p  = 0.000), and the frequency of allele A was found to be remarkably higher in the patients than the controls (48.1% vs. 40.3%, OR = 1.19, p  = 0.000). Multivariate logistic analysis showed that the incidence of CHD was positively correlated with hyperlipidemia, T2D and rs11057401 AA/AT genotypes. The FPG, TC, and ApoA1 levels in the CHD patients were different among the AA, AT and TT genotypes ( P  < 0.05), the A allele carriers had higher FPG, TC and lower ApoA1 levels than the A allele non-carriers ( P  < 0.05). Conclusion The genotypic and allelic frequencies of the rs11057401 SNP were significantly different between the patients with CHD and controls. Subjects with AA genotype or A allele were associated with an increased risk of CHD. The AA/AT genotypes were also associated with increased serum FPG, TC and decreased ApoA1 in CHD.